Dabur India Limited is a public limited company with over 40,000 shareholders. In the last year, the Company has taken steps for moving towards professional Corporate Governance processes. Which include reducing the number of Promoter Directors to 4 and appointing management professionals in the strategic decision-making positions. The Company is now governed by the CEO, the Management Committee and the Board of Directors comprising 10 members.

In the financial year 2006-07, Dabur posted a turnover of Rs 2233.72 crore, a jump of 17.6 per cent over Rs 1899.57 crore earned in 2005-06.

Dr. Anand Burman is the Chairman of Dabur India Limited and Mr Sunil Duggal is the CEO of the company.

You can download a copy of the latest Annual Report from the Investor Relations section of our site.

Dabur has traditionally specialised in nature-based products and Ayurvedic formulations. Over the years we have developed two distinct businesses – FMCG and Pharmaceuticals. Dabur’s FMCG business comprises of 3 sections - Personal Care, Health Care and Foods. Ayurvedic Specialities deals in pure Ayurvedic medicines while the Pharmaceuticals division offers branded pharmaceuticals, oncology and bulk pharma exports. To know more about our products, view the Products section on our site.

You can register on the Media section to get alerts, regular updates and Press Releases on Dabur.

You can access past newspaper reports on the Company from our News archive in the Media section.